trastuzumab
Pertuzumab และ Trastuzumab ในมะเร็งเต้านม HER2-Positive ระยะเริ่มเป็น
Trastuzumab prolongs survival in metastatic breast cancer patients whose tumors over express HER2 It is effective when given as a single agent or in
เว็บไซต์ trastuzumab Trastuzumab prolongs survival in metastatic breast cancer patients whose tumors over express HER2 It is effective when given as a single agent or in trastuzumab Trastuzumab deruxtecan is a HER2 directed antibody-drug conjugate The humanized IgG1 monoclonal antibody is linked to
trastuzumab Descriptions Trastuzumab injection is used to treat HER2-overexpressing new or metastatic breast cancer It can be Trastuzumab has also been shown to penetrate an impaired blood–brain barrier to a limited degree, such as during radiotherapy, and intrathecal delivery of In 2006, trastuzumab plus chemotherapy was approved to treat patients after their HER2-overexpressing breast tumors were surgically removed
ไม่สามารถโหลดการรับสินค้าได้ ความพร้อมใช้งาน
